Life Sciences

OrisDx

The University of Chicago

OrisDX is developing a molecular biomarker next-generation sequencing-based, low-cost, rapid, and accurate test aimed at detecting DNA mutations in the saliva for testing and screening of oral cancer.

This company will be presenting on Day 2 of DeepTechU 2022. View schedule >>